FDA Inspection 1279775 — Mary Bird Perkins Cancer Center

Mary Bird Perkins Cancer Center — FEI 3007686648

The FDA completed an inspection of Mary Bird Perkins Cancer Center on August 18, 2025 in Houma, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 18, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houma, LA (United States)